{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:41:43Z","timestamp":1776670903160,"version":"3.51.2"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Diagnostic subtype has been suggested as a determinant of inequity for people with dementia; its impact on primary care provision is underexplored. This study investigated the association between dementia subtype and likelihood of receiving guideline-consistent primary care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>Retrospective cohort study using Clinical Practice Research Datalink (Aurum) database, 1.1.2006-30.06.2024. We examined potential inequity with eight dementia subtypes: Alzheimer\u2019s disease (AD), Lewy body dementia (LBD), vascular, frontotemporal, unspecified, other and two mixed categories. Six outcomes were examined: care plan or medication review (both within 24\u00a0months of index) and four indicators of potentially inappropriate prescribing (PIP) (high anti-cholinergic burden drugs, z-drugs, benzodiazepines and anti-psychotics). Cox-regression models were used, adjusting for: age, sex, comorbidities, deprivation and ethnicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 571 663 people were included and 72.1% received a care plan; 79.4% received a medication review within 24\u00a0months. Compared to AD: people with mixed dementias were more likely to receive a care plan [hazard ratio (HR) 1.29, 95% confidence interval (CI) 1.26\u20131.32 for mixed including AD\/LBD, HR 1.37, 1.32\u20131.43 for mixed non-AD\/LBD]. All other subtypes were less likely to receive a care plan. Individuals with mixed AD\/LBD (HR 1.28, 1.26\u20131.32), mixed non-AD\/LBD (HR 1.35, 1.26\u20131.45), vascular (HR 1.05, CI 1.04\u20131.07), LBD (HR 1.02, 1.01\u20131.04) and unspecified (HR 1.02, 1.01\u20131.03) were more likely to receive medication reviews. Compared to AD, all other subtypes were more likely to experience PIP across all four indicators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We found greater likelihood of PIP in people with non-AD dementias, a novel finding. Further research is needed, especially with new AD drugs potentially widening disparities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ageing\/afag101","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T11:45:04Z","timestamp":1775648704000},"source":"Crossref","is-referenced-by-count":0,"title":["How does diagnostic subtype affect the quality of primary care for people with dementia? A retrospective cohort study in 1490 English general practices"],"prefix":"10.1093","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9047-0481","authenticated-orcid":false,"given":"Charlotte","family":"Morris","sequence":"first","affiliation":[{"name":"Division of Population Health, Health Services Research and Primary Care School of Health Sciences, The University of Manchester , Manchester , M13 9PL,","place":["UK"]},{"name":"NIHR Greater Manchester Patient Safety Research Collaboration, The University of Manchester , Manchester , M13 9PL,","place":["UK"]},{"name":"NIHR School for Primary Care Research, The University of Manchester , Manchester , M13 9PL,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pearl L H","family":"Mok","sequence":"additional","affiliation":[{"name":"NIHR Greater Manchester Patient Safety Research Collaboration, The University of Manchester , Manchester , M13 9PL,","place":["UK"]},{"name":"Division of Pharmacy and Optometry, School of Health Sciences, The University of Manchester , Manchester, England , M13 9PL,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dame Louise","family":"Robinson","sequence":"additional","affiliation":[{"name":"Population Health Science Institute, Faculty of Medical Science, University of Newcastle upon Tyne , Newcastle upon Tyne , NE1 7RU,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darren M","family":"Ashcroft","sequence":"additional","affiliation":[{"name":"Population Health Science Institute, Faculty of Medical Science, University of Newcastle upon Tyne , Newcastle upon Tyne , NE1 7RU,","place":["UK"]},{"name":"NIHR Greater Manchester Patient Safety Research Collaboration, The University of Manchester , Manchester, England , M13 9PL,","place":["UK"]},{"name":"NIHR School for Primary Care Research, The University of Manchester , Manchester, England , M13 9PL,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Blakeman","sequence":"additional","affiliation":[{"name":"Division of Population Health, Health Services Research and Primary Care School of Health Sciences, The University of Manchester , Manchester , M13 9PL,","place":["UK"]},{"name":"NIHR Greater Manchester Patient Safety Research Collaboration, The University of Manchester , Manchester , M13 9PL,","place":["UK"]},{"name":"NIHR School for Primary Care Research, The University of Manchester , Manchester , M13 9PL,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6450-5815","authenticated-orcid":false,"given":"Evangelos","family":"Kontopantelis","sequence":"additional","affiliation":[{"name":"Division of informatics, Imaging and Data Sciences, The University of Manchester , Manchester ,","place":["UK"]},{"name":"Division of Family Medicine, Yong Loo Lin School of Medicine, National University of Singapore , Singapore 119228 ,","place":["Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"2026042002460901200_ref1","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019","volume":"7","author":"Global Burden of Disease 2019 Dementia Forecasting Collaborators","year":"2022","journal-title":"Lancet Public Health"},{"key":"2026042002460901200_ref2","article-title":"World Alzheimer report 2022: life after diagnosis: navigating treatment, care and support","author":"Gauthier","year":"2022","journal-title":"International"},{"key":"2026042002460901200_ref3","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jamda.2016.04.026","article-title":"Who is providing the predominant Care for Older Adults with dementia?","volume":"17","author":"Yang","year":"2016","journal-title":"J Am Med Dir Assoc"},{"key":"2026042002460901200_ref4","first-page":"NG97","volume-title":"NICE: National Institute for Health and Care Excellence","author":"NICE","year":"2018"},{"key":"2026042002460901200_ref5","first-page":"1","article-title":"Suspecting dementia: canaries, chameleons and zebras","volume":"0","author":"Warren","year":"2021","journal-title":"Pract Neurol"},{"key":"2026042002460901200_ref6","volume-title":"Dementia Statistics Hub","year":"2023"},{"key":"2026042002460901200_ref7","first-page":"398","article-title":"Evaluation of suspected dementia","volume":"97","author":"Falk","year":"2018","journal-title":"Am Fam Physician"},{"key":"2026042002460901200_ref8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/WAD.0b013e3181a6bebc","article-title":"Missed and delayed diagnosis of dementia in primary care: prevalence and contributing factors","volume":"23","author":"Bradford","year":"2009","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2026042002460901200_ref9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12877-019-1174-3","article-title":"Prevalence of dementia diagnoses not otherwise specified in eight European countries: a cross-sectional cohort study","volume":"19","author":"Lethin","year":"2019","journal-title":"BMC Geriatr"},{"key":"2026042002460901200_ref10","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1016\/S2666-7568(23)00019-3","article-title":"The prevalence, correlation, and co-occurrence of neuropathology in old age: harmonisation of 12 measures across six community-based autopsy studies of dementia","volume":"4","author":"Nichols","year":"2023","journal-title":"Lancet Healthy Longev"},{"key":"2026042002460901200_ref11","doi-asserted-by":"publisher","first-page":"c4670","DOI":"10.1136\/bmj.c4670","article-title":"What do we mean by Alzheimer\u2019s disease?","volume":"341","author":"Richards","year":"2010","journal-title":"BMJ"},{"key":"2026042002460901200_ref12","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1093\/ageing\/afab164","article-title":"What gets recorded, counts: dementia recording in primary care compared with a specialist database","volume":"50","author":"Davis","year":"2021","journal-title":"Age Ageing"},{"key":"2026042002460901200_ref13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013306.pub2","article-title":"Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis","author":"Battle","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2026042002460901200_ref14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12916-018-1135-2","article-title":"Dementia subtype and living well: results from the improving the experience of dementia and enhancing active life (IDEAL) study","volume":"16","author":"Wu","year":"2018","journal-title":"BMC Med"},{"key":"2026042002460901200_ref15","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 updated AGS beers criteria(R) for potentially inappropriate medication use in older adults","volume":"67","author":"American Geriatrics Society 2019 Beers Criteria Update Expert Panel","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"2026042002460901200_ref16","doi-asserted-by":"publisher","first-page":"e076268","DOI":"10.1136\/bmj-2023-076268","article-title":"Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study","volume":"385","author":"Mok","year":"2024","journal-title":"BMJ"},{"key":"2026042002460901200_ref17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.5770\/cgj.19.233","article-title":"Quality of dementia care in the community: identifying key quality assurance components","volume":"19","author":"Heckman","year":"2016","journal-title":"Can Geriatr J"},{"key":"2026042002460901200_ref18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12939-024-02245-w","article-title":"A new model to understand the complexity of inequalities in dementia","volume":"23","author":"Giebel","year":"2024","journal-title":"Int J Equity Health"},{"key":"2026042002460901200_ref19","doi-asserted-by":"publisher","first-page":"e70035","DOI":"10.1002\/gps.70035","article-title":"Inequalities in the quality and safety of post-diagnostic primary care for people with dementia: a scoping review","volume":"39","author":"Morris","year":"2024","journal-title":"Int J Geriatr Psychiatry"},{"key":"2026042002460901200_ref20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1108\/JICA-02-2020-0005","article-title":"Mapping post-diagnostic dementia care in England: An e-survey","volume":"29","author":"Frost","year":"2021","journal-title":"J Integr Care"},{"key":"2026042002460901200_ref21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/ageing\/afw208","article-title":"Inequalities in receipt of mental and physical healthcare in people with dementia in the UK","volume":"46","author":"Cooper","year":"2016","journal-title":"Age Ageing"},{"key":"2026042002460901200_ref22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2147\/CLEP.S222126","article-title":"Differences in psychotropic drug prescribing between ethnic groups of people with dementia in the United Kingdom","volume":"12","author":"Jones","year":"2020","journal-title":"Clin Epidemiol"},{"key":"2026042002460901200_ref23","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jalz.2015.02.008","article-title":"Caring for dementia: a population-based study examining variations in guideline-consistent medical care","volume":"11","author":"Sivananthan","year":"2015","journal-title":"Alzheimers Dement"},{"key":"2026042002460901200_ref24","volume-title":"CPRD: UK Data Driving Real World Evidence [Internet]","author":"Medicines and Healthcare Products Regulatory Agency","year":"2024"},{"key":"2026042002460901200_ref25","article-title":"Clinical codelist - dementia I [Internet]","author":"","year":"2021"},{"key":"2026042002460901200_ref26","article-title":"PCDSEARCH: Stata module to extract code lists from primary care databases","author":"Kontopantelis","year":"2015","journal-title":"Stat Software Components"},{"key":"2026042002460901200_ref27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1136\/jech-2017-209999","article-title":"Geographical epidemiology of health and overall deprivation in England, its changes and persistence from 2004 to 2015: a longitudinal spatial population study","volume":"72","author":"Kontopantelis","year":"2018","journal-title":"J Epidemiol Community Health"},{"key":"2026042002460901200_ref28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10654-018-0442-4","article-title":"Approach to record linkage of primary care data from clinical practice research datalink to other health-related patient data: overview and implications","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"2026042002460901200_ref29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12963-023-00302-0","article-title":"Completeness, agreement, and representativeness of ethnicity recording in the United Kingdom\u2019s clinical practice research datalink (CPRD) and linked hospital episode statistics (HES)","volume":"21","author":"Shiekh","year":"2023","journal-title":"Popul Health Metr"},{"key":"2026042002460901200_ref30","author":"","year":"2023"},{"key":"2026042002460901200_ref31","volume-title":"SIGN 168: Assessment, diagnosis, care and support for people with dementia and their carers: A national clinical guideline [Internet]","year":"2023"},{"key":"2026042002460901200_ref32","volume-title":"Drugs on the ACB Scale [Internet]","author":"University of East Anglia","year":"2012"},{"key":"2026042002460901200_ref33","first-page":"361","article-title":"Medications with potent anticholinergic activity and incident dementia diagnosis in the UK older population","volume":"25","author":"Richardson","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2026042002460901200_ref34","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s12916-020-01821-5","article-title":"Adverse effects of Z-drugs for sleep disturbance in people living with dementia: a population-based cohort study","volume":"18","author":"Richardson","year":"2020","journal-title":"BMC Med"},{"key":"2026042002460901200_ref35","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3233\/JAD-180353","article-title":"Anticholinergic burden and risk of stroke and death in people with different types of dementia","volume":"65","author":"Tan","year":"2018","journal-title":"J Alzheimer\u2019s Dis"},{"key":"2026042002460901200_ref36","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1080\/13607863.2020.1830028","article-title":"Anticholinergic drug use and risk of mortality for people with dementia in Northern Ireland","volume":"25","author":"McMichael","journal-title":"Aging Ment Health"},{"key":"2026042002460901200_ref37","volume-title":"A Report for the Minister of State for Care Services","author":"Banerjee","year":"2009"},{"key":"2026042002460901200_ref38","doi-asserted-by":"publisher","first-page":"E107","DOI":"10.1503\/cmaj.190757","article-title":"Development and validation of the Cambridge multimorbidity score","volume":"192","author":"Payne","year":"2020","journal-title":"CMAJ"},{"key":"2026042002460901200_ref39","author":"","year":"2014","journal-title":"Dementia UK: second edition overview"},{"key":"2026042002460901200_ref40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0289893","article-title":"South Asian, black and white ethnicity and the effect of potentially modifiable risk factors for dementia: a study in English electronic health records","volume":"18","author":"Mukadam","year":"2023","journal-title":"PLoS One"},{"key":"2026042002460901200_ref41","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/gps.5046","article-title":"Ethnic differences in cognition and age in people diagnosed with dementia: a study of electronic health records in two large mental healthcare providers","volume":"34","author":"Mukadam","year":"2019","journal-title":"Int J Geriatr Psychiatry"},{"key":"2026042002460901200_ref42","volume-title":"Lancet Healthy Longev","author":"","year":"2022"},{"key":"2026042002460901200_ref43","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.ridd.2013.02.021","article-title":"Incidence of dementia in older adults with intellectual disabilities","volume":"34","author":"Strydom","year":"2013","journal-title":"Res Dev Disabil"},{"key":"2026042002460901200_ref44","doi-asserted-by":"publisher","first-page":"e012546","DOI":"10.1136\/bmjopen-2016-012546","article-title":"Association of comorbidity and health service usage among patients with dementia in the UK: a population-based study","volume":"7","author":"Browne","year":"2017","journal-title":"BMJ Open"},{"key":"2026042002460901200_ref45","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S2215-0366(25)00261-5","article-title":"Antipsychotic prescriptions in people with dementia in primary care: a cohort study investigating adherence of dose and duration to UK clinical guidelines","volume":"12","author":"Smith","year":"2025","journal-title":"Lancet Psychiatry"},{"key":"2026042002460901200_ref46","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/13607863.2020.1857697","article-title":"\u2018They simply do not understand\u2019: a focus group study exploring the lived experiences of family caregivers of people with frontotemporal dementia","volume":"26","author":"Bruinsma","year":"2022","journal-title":"Aging Ment Health"},{"key":"2026042002460901200_ref47","volume-title":"Quality and Outcomes Framework Guidance for 2022\/23","author":"NHS England","year":"2022"},{"key":"2026042002460901200_ref48","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.3399\/bjgp12X625148","article-title":"Quality of care provided to people with dementia: utilisation and quality of the annual dementia review in general practice","volume":"62","author":"Connolly","year":"2012","journal-title":"Br J Gen Pract"},{"key":"2026042002460901200_ref49","doi-asserted-by":"publisher","DOI":"10.3399\/BJGP.2025.0407","volume":"76","author":"","year":"2026","journal-title":"Br J Gen Pract"},{"key":"2026042002460901200_ref50","doi-asserted-by":"publisher","DOI":"10.1101\/2022.01.21.22269634","volume-title":"The Primary Care Annual Dementia Review: A Qualitative Study of the Views and Experiences of Service Users and Providers","author":"Wheatley","year":"2022"},{"key":"2026042002460901200_ref51","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1136\/jech-2022-219200","article-title":"Completeness and representativeness of small area socioeconomic data linked with the UK clinical practice research datalink (CPRD)","volume":"76","author":"Mahadevan","year":"2022","journal-title":"J Epidemiol Community Health"},{"key":"2026042002460901200_ref52","doi-asserted-by":"publisher","first-page":"r1148","DOI":"10.1136\/bmj.r1148","article-title":"Alzheimer\u2019s disease: rise in new drugs being trialled sparks hope among experts","volume":"389","author":"Mahase","year":"2025","journal-title":"BMJ"},{"key":"2026042002460901200_ref53","doi-asserted-by":"publisher","first-page":"100061","DOI":"10.1016\/j.lanprc.2025.100061","article-title":"Dementia, more than a diagnosis and drugs: perspectives from primary care on the new therapeutic era for Alzheimer\u2019s disease","volume":"1","author":"Foley","year":"2024","journal-title":"Lancet Healthy Longev"}],"container-title":["Age and Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/55\/4\/afag101\/68113526\/afag101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/55\/4\/afag101\/68113526\/afag101.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T06:46:15Z","timestamp":1776667575000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ageing\/article\/doi\/10.1093\/ageing\/afag101\/8659069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ageing\/afag101","relation":{},"ISSN":["0002-0729","1468-2834"],"issn-type":[{"value":"0002-0729","type":"print"},{"value":"1468-2834","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,4]]},"article-number":"afag101"}}